Download presentation
Presentation is loading. Please wait.
Published byMarc-Antoine Bessette Modified over 5 years ago
1
Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial Robert Boostanfar, M.D., Davis Gates, Ph.D., Yanfen Guan, M.S., Keith Gordon, Ph.D., Christine McCrary Sisk, B.S., Barbara J. Stegmann, M.D. Fertility and Sterility Volume 106, Issue 2, Pages e5 (August 2016) DOI: /j.fertnstert Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions
2
Figure 1 Cumulative vital pregnancy rate. CFA = corifollitropin alfa; rFSH = recombinant follicle-stimulating hormone. Fertility and Sterility , e5DOI: ( /j.fertnstert ) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions
3
Figure 2 Cumulative live-birth rate. CFA = corifollitropin alfa; rFSH = recombinant follicle-stimulating hormone. Fertility and Sterility , e5DOI: ( /j.fertnstert ) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions
4
Supplemental Figure 1 Women reaching pregnancy and live birth. CFA = corifollitropin alfa; FTET = frozen-thawed embryo transfer; rFSH = recombinant follicle-stimulating hormone. Fertility and Sterility , e5DOI: ( /j.fertnstert ) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions
5
Supplemental Figure 2 Vital pregnancy rates (per cycle) in the PURSUE and FTET follow-up studies. CFA = corifollitropin alfa; FTET = frozen-thawed embryo transfer; rFSH = recombinant follicle-stimulating hormone. Fertility and Sterility , e5DOI: ( /j.fertnstert ) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.